Thursday October 22, 2020

Rebel Trinity investors aim to overcome egm loophole

A group of shareholders owning 10 per cent of Nasdaq-listed Bray medical firm Trinity Biotech are to spend almost $170,000 (€130,000) to overcome a loophole in Irish company law that has prevented them from demanding an egm aimed at ousting the compa

29th November, 2008

A group of shareholders owning 10 per cent of Nasdaq-listed Bray medical firm Trinity Biotech are to spend almost $170,000 (€130,000) to overcome a loophole in Irish company law that has prevented them from demanding an egm aimed at ousting the company’s board.

The shareholder group, headed by Kansas-based investor Tom Reidy, initiated its action earlier this month after the Trinity board, led by chairman and chief executive Ronan O’Caoimh, ruled a previous attempt to...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 9 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 5 years ago